AIG
PRTK

American International Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

American International Group’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,316
Closed -$72K – 3339
2022
Q1 		$72K Sell
24,316
-1,712
-7% -$6.44K ﹤0.01% 2722
2021
Q4 		$117K Sell
26,028
-33
-0.1% -$157 ﹤0.01% 2653
2021
Q3 		$127K Buy
26,061
+407
+2% +$2.24K ﹤0.01% 2682
2021
Q2 		$175 Buy
25,654
+235
+0.9% +$1.9K ﹤0.01% 2598
2021
Q1 		$179 Buy
25,419
+67
+0.3% +$482 ﹤0.01% 2426
2020
Q4 		$159 Sell
25,352
-728
-3% -$4.28K ﹤0.01% 2400
2020
Q3 		$141K Buy
26,080
+1,140
+5% +$5.64K ﹤0.01% 2340
2020
Q2 		$130K Buy
24,940
+5,483
+28% +$24.4K ﹤0.01% 2362
2020
Q1 		$61K Sell
19,457
-1,125
-5% -$4.15K ﹤0.01% 2587
2019
Q4 		$83K Buy
20,582
+370
+2% +$1.28K ﹤0.01% 2720
2019
Q3 		$87K Sell
20,212
-141
-0.7% -$564 ﹤0.01% 2692
2019
Q2 		$81K Sell
20,353
-168
-0.8% -$799 ﹤0.01% 2787
2019
Q1 		$110K Sell
20,521
-213
-1% -$1.38K ﹤0.01% 2569
2018
Q4 		$106K Sell
20,734
-160
-0.8% -$1.22K ﹤0.01% 2564
2018
Q3 		$203K Buy
20,894
+377
+2% +$3.8K ﹤0.01% 2412
2018
Q2 		$209K Buy
20,517
+3,469
+20% +$39.3K ﹤0.01% 2329
2018
Q1 		$222K Buy
17,048
+1,010
+6% +$15K ﹤0.01% 2195
2017
Q4 		$287K Buy
16,038
+234
+1% +$4.88K ﹤0.01% 2101
2017
Q3 		$397K Buy
15,804
+1,182
+8% +$27.5K ﹤0.01% 1894
2017
Q2 		$352K Buy
14,622
+3,511
+32% +$77.6K ﹤0.01% 1935
2017
Q1 		$214K Buy
11,111
+2,824
+34% +$44.5K ﹤0.01% 2140
2016
Q4 		$128K Sell
8,287
-22
-0.3% -$286 ﹤0.01% 2460
2016
Q3 		$108K Buy
8,309
+12
+0.1% +$159 ﹤0.01% 2555
2016
Q2 		$115K Buy
8,297
+1,156
+16% +$17K ﹤0.01% 2513
2016
Q1 		$108K Hold
7,141
– – ﹤0.01% 3365
2015
Q4 		$135K Sell
7,141
-13
-0.2% -$248 ﹤0.01% 3228
2015
Q3 		$136K Buy
7,154
+8
+0.1% +$199 ﹤0.01% 3178
2015
Q2 		$184K Buy
+7,146
New +$203K ﹤0.01% 3086
2013
Q3 		– Sell
-724
Closed -$26.2K – 4783
2013
Q2 		$26.2K Buy
+724
New +$31K ﹤0.01% 3831

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

American International Group's PRTK Position: Q2 2022 in Review

American International Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 24,316 shares — an estimated $72K sold.

American International Group first reported a position in PRTK in Q2 2013 and held it in 29 quarters. The position peaked at $397K in Q3 2017. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

  • American International Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 24,316 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $72K.
  • American International Group first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
  • American International Group's Paratek Pharmaceuticals, Inc. position peaked at $397K in Q3 2017.
  • 84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.